Table of Content

1 Report Overview
1.1 Chagas Disease Drug Definition
1.2 Market by Type
1.2.1 Global Chagas Disease Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Cz-007
1.2.3 Cz-008
1.2.4 D-121
1.2.5 DNDI-0690
1.2.6 EPLBS-1246
1.2.7 EPLBS-967
1.2.8 Others
1.3 Market Segment by Application
1.3.1 Global Chagas Disease Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Chagas Disease Drug Sales
2.1 Global Chagas Disease Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Chagas Disease Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Chagas Disease Drug Revenue by Region
2.3.1 Global Chagas Disease Drug Revenue by Region (2018-2023)
2.3.2 Global Chagas Disease Drug Revenue by Region (2024-2034)
2.4 Global Chagas Disease Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Chagas Disease Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Chagas Disease Drug Sales Quantity by Region
2.6.1 Global Chagas Disease Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Chagas Disease Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Chagas Disease Drug Sales Quantity by Manufacturers
3.1.1 Global Chagas Disease Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Chagas Disease Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Chagas Disease Drug Sales in 2024
3.2 Global Chagas Disease Drug Revenue by Manufacturers
3.2.1 Global Chagas Disease Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Chagas Disease Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Chagas Disease Drug Revenue in 2024
3.3 Global Chagas Disease Drug Sales Price by Manufacturers
3.4 Global Key Players of Chagas Disease Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Chagas Disease Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Chagas Disease Drug, Product Offered and Application
3.8 Global Key Manufacturers of Chagas Disease Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Chagas Disease Drug Sales Quantity by Type
4.1.1 Global Chagas Disease Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Chagas Disease Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Chagas Disease Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Chagas Disease Drug Revenue by Type
4.2.1 Global Chagas Disease Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Chagas Disease Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Chagas Disease Drug Revenue Market Share by Type (2018-2034)
4.3 Global Chagas Disease Drug Price by Type
4.3.1 Global Chagas Disease Drug Price by Type (2018-2023)
4.3.2 Global Chagas Disease Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Chagas Disease Drug Sales Quantity by Application
5.1.1 Global Chagas Disease Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Chagas Disease Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Chagas Disease Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Chagas Disease Drug Revenue by Application
5.2.1 Global Chagas Disease Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Chagas Disease Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Chagas Disease Drug Revenue Market Share by Application (2018-2034)
5.3 Global Chagas Disease Drug Price by Application
5.3.1 Global Chagas Disease Drug Price by Application (2018-2023)
5.3.2 Global Chagas Disease Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Chagas Disease Drug Sales by Company
6.1.1 North America Chagas Disease Drug Revenue by Company (2018-2023)
6.1.2 North America Chagas Disease Drug Sales Quantity by Company (2018-2023)
6.2 North America Chagas Disease Drug Market Size by Type
6.2.1 North America Chagas Disease Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Chagas Disease Drug Revenue by Type (2018-2034)
6.3 North America Chagas Disease Drug Market Size by Application
6.3.1 North America Chagas Disease Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Chagas Disease Drug Revenue by Application (2018-2034)
6.4 North America Chagas Disease Drug Market Size by Country
6.4.1 North America Chagas Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Chagas Disease Drug Revenue by Country (2018-2034)
6.4.3 North America Chagas Disease Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Chagas Disease Drug Sales by Company
7.1.1 Europe Chagas Disease Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Chagas Disease Drug Revenue by Company (2018-2023)
7.2 Europe Chagas Disease Drug Market Size by Type
7.2.1 Europe Chagas Disease Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Chagas Disease Drug Revenue by Type (2018-2034)
7.3 Europe Chagas Disease Drug Market Size by Application
7.3.1 Europe Chagas Disease Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Chagas Disease Drug Revenue by Application (2018-2034)
7.4 Europe Chagas Disease Drug Market Size by Country
7.4.1 Europe Chagas Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Chagas Disease Drug Revenue by Country (2018-2034)
7.4.3 Europe Chagas Disease Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Chagas Disease Drug Sales by Company
8.1.1 China Chagas Disease Drug Sales Quantity by Company (2018-2023)
8.1.2 China Chagas Disease Drug Revenue by Company (2018-2023)
8.2 China Chagas Disease Drug Market Size by Type
8.2.1 China Chagas Disease Drug Sales Quantity by Type (2018-2034)
8.2.2 China Chagas Disease Drug Revenue by Type (2018-2034)
8.3 China Chagas Disease Drug Market Size by Application
8.3.1 China Chagas Disease Drug Sales Quantity by Application (2018-2034)
8.3.2 China Chagas Disease Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Chagas Disease Drug Sales by Company
9.1.1 APAC Chagas Disease Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Chagas Disease Drug Revenue by Company (2018-2023)
9.2 APAC Chagas Disease Drug Market Size by Type
9.2.1 APAC Chagas Disease Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Chagas Disease Drug Revenue by Type (2018-2034)
9.3 APAC Chagas Disease Drug Market Size by Application
9.3.1 APAC Chagas Disease Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Chagas Disease Drug Revenue by Application (2018-2034)
9.4 APAC Chagas Disease Drug Market Size by Region
9.4.1 APAC Chagas Disease Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Chagas Disease Drug Revenue by Region (2018-2034)
9.4.3 APAC Chagas Disease Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Chagas Disease Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Chagas Disease Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Chagas Disease Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Chagas Disease Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Chagas Disease Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Chagas Disease Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Chagas Disease Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Chagas Disease Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Chagas Disease Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Information
11.1.2 AstraZeneca Plc Overview
11.1.3 AstraZeneca Plc Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 AstraZeneca Plc Chagas Disease Drug Products and Services
11.1.5 AstraZeneca Plc Chagas Disease Drug SWOT Analysis
11.1.6 AstraZeneca Plc Recent Developments
11.2 Bayer AG
11.2.1 Bayer AG Company Information
11.2.2 Bayer AG Overview
11.2.3 Bayer AG Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Bayer AG Chagas Disease Drug Products and Services
11.2.5 Bayer AG Chagas Disease Drug SWOT Analysis
11.2.6 Bayer AG Recent Developments
11.3 Daiichi Sankyo Co Ltd
11.3.1 Daiichi Sankyo Co Ltd Company Information
11.3.2 Daiichi Sankyo Co Ltd Overview
11.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Daiichi Sankyo Co Ltd Chagas Disease Drug Products and Services
11.3.5 Daiichi Sankyo Co Ltd Chagas Disease Drug SWOT Analysis
11.3.6 Daiichi Sankyo Co Ltd Recent Developments
11.4 Eisai Co Ltd
11.4.1 Eisai Co Ltd Company Information
11.4.2 Eisai Co Ltd Overview
11.4.3 Eisai Co Ltd Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Eisai Co Ltd Chagas Disease Drug Products and Services
11.4.5 Eisai Co Ltd Chagas Disease Drug SWOT Analysis
11.4.6 Eisai Co Ltd Recent Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Company Information
11.5.2 GlaxoSmithKline Plc Overview
11.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 GlaxoSmithKline Plc Chagas Disease Drug Products and Services
11.5.5 GlaxoSmithKline Plc Chagas Disease Drug SWOT Analysis
11.5.6 GlaxoSmithKline Plc Recent Developments
11.6 Grupo Praxis Pharmaceutical SA
11.6.1 Grupo Praxis Pharmaceutical SA Company Information
11.6.2 Grupo Praxis Pharmaceutical SA Overview
11.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Products and Services
11.6.5 Grupo Praxis Pharmaceutical SA Chagas Disease Drug SWOT Analysis
11.6.6 Grupo Praxis Pharmaceutical SA Recent Developments
11.7 Humanigen Inc
11.7.1 Humanigen Inc Company Information
11.7.2 Humanigen Inc Overview
11.7.3 Humanigen Inc Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Humanigen Inc Chagas Disease Drug Products and Services
11.7.5 Humanigen Inc Chagas Disease Drug SWOT Analysis
11.7.6 Humanigen Inc Recent Developments
11.8 Kancera AB
11.8.1 Kancera AB Company Information
11.8.2 Kancera AB Overview
11.8.3 Kancera AB Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Kancera AB Chagas Disease Drug Products and Services
11.8.5 Kancera AB Chagas Disease Drug SWOT Analysis
11.8.6 Kancera AB Recent Developments
11.9 Merck & Co Inc
11.9.1 Merck & Co Inc Company Information
11.9.2 Merck & Co Inc Overview
11.9.3 Merck & Co Inc Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Merck & Co Inc Chagas Disease Drug Products and Services
11.9.5 Merck & Co Inc Chagas Disease Drug SWOT Analysis
11.9.6 Merck & Co Inc Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Company Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Novartis AG Chagas Disease Drug Products and Services
11.10.5 Novartis AG Chagas Disease Drug SWOT Analysis
11.10.6 Novartis AG Recent Developments
11.11 Oblita Therapeutics BVBA
11.11.1 Oblita Therapeutics BVBA Company Information
11.11.2 Oblita Therapeutics BVBA Overview
11.11.3 Oblita Therapeutics BVBA Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Oblita Therapeutics BVBA Chagas Disease Drug Products and Services
11.11.5 Oblita Therapeutics BVBA Recent Developments
11.12 Sanofi
11.12.1 Sanofi Company Information
11.12.2 Sanofi Overview
11.12.3 Sanofi Chagas Disease Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Sanofi Chagas Disease Drug Products and Services
11.12.5 Sanofi Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Chagas Disease Drug Value Chain Analysis
12.2 Chagas Disease Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Chagas Disease Drug Production Mode & Process
12.4 Chagas Disease Drug Sales and Marketing
12.4.1 Chagas Disease Drug Sales Channels
12.4.2 Chagas Disease Drug Distributors
12.5 Chagas Disease Drug Customers
13 Market Dynamics
13.1 Chagas Disease Drug Industry Trends
13.2 Chagas Disease Drug Market Drivers
13.3 Chagas Disease Drug Market Challenges
13.4 Chagas Disease Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Chagas Disease Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Cz-007
Table 3. Major Manufacturers of Cz-008
Table 4. Major Manufacturers of D-121
Table 5. Major Manufacturers of DNDI-0690
Table 6. Major Manufacturers of EPLBS-1246
Table 7. Major Manufacturers of EPLBS-967
Table 8. Major Manufacturers of Others
Table 9. Global Chagas Disease Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Chagas Disease Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 11. Global Chagas Disease Drug Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global Chagas Disease Drug Revenue Market Share by Region (2018-2023)
Table 13. Global Chagas Disease Drug Revenue by Region (2024-2034) & (US$ Million)
Table 14. Global Chagas Disease Drug Revenue Market Share by Region (2024-2034)
Table 15. Global Chagas Disease Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 16. Global Chagas Disease Drug Sales by Region (2018-2023) & (K Pcs)
Table 17. Global Chagas Disease Drug Sales Market Share by Region (2018-2023)
Table 18. Global Chagas Disease Drug Sales by Region (2024-2034) & (K Pcs)
Table 19. Global Chagas Disease Drug Sales Market Share by Region (2024-2034)
Table 20. Global Chagas Disease Drug Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 21. Global Chagas Disease Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 22. Global Chagas Disease Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global Chagas Disease Drug Revenue Share by Manufacturers (2018-2023)
Table 24. Global Chagas Disease Drug Price by Manufacturers 2018-2023 (USD/Pcs)
Table 25. Global Key Players of Chagas Disease Drug, Industry Ranking, 2021 VS 2024
Table 26. Global Chagas Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Chagas Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chagas Disease Drug as of 2024)
Table 28. Global Key Manufacturers of Chagas Disease Drug, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Chagas Disease Drug, Product Offered and Application
Table 30. Global Key Manufacturers of Chagas Disease Drug, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Chagas Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 33. Global Chagas Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 34. Global Chagas Disease Drug Sales Quantity Share by Type (2018-2023)
Table 35. Global Chagas Disease Drug Sales Quantity Share by Type (2024-2034)
Table 36. Global Chagas Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global Chagas Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 38. Global Chagas Disease Drug Revenue Share by Type (2018-2023)
Table 39. Global Chagas Disease Drug Revenue Share by Type (2024-2034)
Table 40. Chagas Disease Drug Price by Type (2018-2023) & (USD/Pcs)
Table 41. Global Chagas Disease Drug Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 42. Global Chagas Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 43. Global Chagas Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 44. Global Chagas Disease Drug Sales Quantity Share by Application (2018-2023)
Table 45. Global Chagas Disease Drug Sales Quantity Share by Application (2024-2034)
Table 46. Global Chagas Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Chagas Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 48. Global Chagas Disease Drug Revenue Share by Application (2018-2023)
Table 49. Global Chagas Disease Drug Revenue Share by Application (2024-2034)
Table 50. Chagas Disease Drug Price by Application (2018-2023) & (USD/Pcs)
Table 51. Global Chagas Disease Drug Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 52. North America Chagas Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 53. North America Chagas Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 54. North America Chagas Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 55. North America Chagas Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 56. North America Chagas Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 57. North America Chagas Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 58. North America Chagas Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 59. North America Chagas Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 60. North America Chagas Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 61. North America Chagas Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 62. North America Chagas Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 63. North America Chagas Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 64. North America Chagas Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 65. North America Chagas Disease Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 66. North America Chagas Disease Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 67. Europe Chagas Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 68. Europe Chagas Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 69. Europe Chagas Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 70. Europe Chagas Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 71. Europe Chagas Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 72. Europe Chagas Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 73. Europe Chagas Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 74. Europe Chagas Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 75. Europe Chagas Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 76. Europe Chagas Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 77. Europe Chagas Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 78. Europe Chagas Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Chagas Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 80. Europe Chagas Disease Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 81. Europe Chagas Disease Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 82. China Chagas Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 83. China Chagas Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 84. China Chagas Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 85. China Chagas Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 86. China Chagas Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 87. China Chagas Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 88. China Chagas Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 89. China Chagas Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 90. China Chagas Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 91. China Chagas Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 92. APAC Chagas Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 93. APAC Chagas Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 94. APAC Chagas Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 95. APAC Chagas Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 96. APAC Chagas Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 97. APAC Chagas Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 98. APAC Chagas Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 99. APAC Chagas Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 100. APAC Chagas Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 101. APAC Chagas Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 102. APAC Chagas Disease Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 103. APAC Chagas Disease Drug Revenue by Region (2018-2023) & (US$ Million)
Table 104. APAC Chagas Disease Drug Revenue by Region (2024-2034) & (US$ Million)
Table 105. APAC Chagas Disease Drug Sales Quantity by Region (2018-2023) & (K Pcs)
Table 106. APAC Chagas Disease Drug Sales Quantity by Region (2024-2034) & (K Pcs)
Table 107. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Chagas Disease Drug Revenue by Company (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 110. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 111. Middle East, Africa and Latin America Chagas Disease Drug Revenue by Type (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Chagas Disease Drug Revenue by Type (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 114. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 115. Middle East, Africa and Latin America Chagas Disease Drug Revenue by Application (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America Chagas Disease Drug Revenue by Application (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Chagas Disease Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 118. Middle East, Africa and Latin America Chagas Disease Drug Revenue by Country (2018-2023) & (US$ Million)
Table 119. Middle East, Africa and Latin America Chagas Disease Drug Revenue by Country (2024-2034) & (US$ Million)
Table 120. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 121. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 122. AstraZeneca Plc Company Information
Table 123. AstraZeneca Plc Description and Overview
Table 124. AstraZeneca Plc Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 125. AstraZeneca Plc Chagas Disease Drug Product and Services
Table 126. AstraZeneca Plc Chagas Disease Drug SWOT Analysis
Table 127. AstraZeneca Plc Recent Developments
Table 128. Bayer AG Company Information
Table 129. Bayer AG Description and Overview
Table 130. Bayer AG Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 131. Bayer AG Chagas Disease Drug Product and Services
Table 132. Bayer AG Chagas Disease Drug SWOT Analysis
Table 133. Bayer AG Recent Developments
Table 134. Daiichi Sankyo Co Ltd Company Information
Table 135. Daiichi Sankyo Co Ltd Description and Overview
Table 136. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 137. Daiichi Sankyo Co Ltd Chagas Disease Drug Product and Services
Table 138. Daiichi Sankyo Co Ltd Chagas Disease Drug SWOT Analysis
Table 139. Daiichi Sankyo Co Ltd Recent Developments
Table 140. Eisai Co Ltd Company Information
Table 141. Eisai Co Ltd Description and Overview
Table 142. Eisai Co Ltd Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 143. Eisai Co Ltd Chagas Disease Drug Product and Services
Table 144. Eisai Co Ltd Chagas Disease Drug SWOT Analysis
Table 145. Eisai Co Ltd Recent Developments
Table 146. GlaxoSmithKline Plc Company Information
Table 147. GlaxoSmithKline Plc Description and Overview
Table 148. GlaxoSmithKline Plc Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 149. GlaxoSmithKline Plc Chagas Disease Drug Product and Services
Table 150. GlaxoSmithKline Plc Chagas Disease Drug SWOT Analysis
Table 151. GlaxoSmithKline Plc Recent Developments
Table 152. Grupo Praxis Pharmaceutical SA Company Information
Table 153. Grupo Praxis Pharmaceutical SA Description and Overview
Table 154. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 155. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product and Services
Table 156. Grupo Praxis Pharmaceutical SA Chagas Disease Drug SWOT Analysis
Table 157. Grupo Praxis Pharmaceutical SA Recent Developments
Table 158. Humanigen Inc Company Information
Table 159. Humanigen Inc Description and Overview
Table 160. Humanigen Inc Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 161. Humanigen Inc Chagas Disease Drug Product and Services
Table 162. Humanigen Inc Chagas Disease Drug SWOT Analysis
Table 163. Humanigen Inc Recent Developments
Table 164. Kancera AB Company Information
Table 165. Kancera AB Description and Overview
Table 166. Kancera AB Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 167. Kancera AB Chagas Disease Drug Product and Services
Table 168. Kancera AB Chagas Disease Drug SWOT Analysis
Table 169. Kancera AB Recent Developments
Table 170. Merck & Co Inc Company Information
Table 171. Merck & Co Inc Description and Overview
Table 172. Merck & Co Inc Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 173. Merck & Co Inc Chagas Disease Drug Product and Services
Table 174. Merck & Co Inc Chagas Disease Drug SWOT Analysis
Table 175. Merck & Co Inc Recent Developments
Table 176. Novartis AG Company Information
Table 177. Novartis AG Description and Overview
Table 178. Novartis AG Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 179. Novartis AG Chagas Disease Drug Product and Services
Table 180. Novartis AG Chagas Disease Drug SWOT Analysis
Table 181. Novartis AG Recent Developments
Table 182. Oblita Therapeutics BVBA Company Information
Table 183. Oblita Therapeutics BVBA Description and Overview
Table 184. Oblita Therapeutics BVBA Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 185. Oblita Therapeutics BVBA Chagas Disease Drug Product and Services
Table 186. Oblita Therapeutics BVBA Recent Developments
Table 187. Sanofi Company Information
Table 188. Sanofi Description and Overview
Table 189. Sanofi Chagas Disease Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 190. Sanofi Chagas Disease Drug Product and Services
Table 191. Sanofi Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Chagas Disease Drug Distributors List
Table 195. Chagas Disease Drug Customers List
Table 196. Chagas Disease Drug Market Trends
Table 197. Chagas Disease Drug Market Drivers
Table 198. Chagas Disease Drug Market Challenges
Table 199. Chagas Disease Drug Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Chagas Disease Drug Product Picture
Figure 2. Global Chagas Disease Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Chagas Disease Drug Market Share by Type in 2024 & 2034
Figure 4. Cz-007 Product Picture
Figure 5. Cz-008 Product Picture
Figure 6. D-121 Product Picture
Figure 7. DNDI-0690 Product Picture
Figure 8. EPLBS-1246 Product Picture
Figure 9. EPLBS-967 Product Picture
Figure 10. Others Product Picture
Figure 11. Global Chagas Disease Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 12. Global Chagas Disease Drug Market Share by Application in 2024 & 2034
Figure 13. Hospital
Figure 14. Clinic
Figure 15. Others
Figure 16. Chagas Disease Drug Report Years Considered
Figure 17. Global Chagas Disease Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Chagas Disease Drug Revenue 2018-2034 (US$ Million)
Figure 19. Global Chagas Disease Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 20. Global Chagas Disease Drug Sales Quantity 2018-2034 (K Pcs)
Figure 21. Global Chagas Disease Drug Sales Quantity Market Share by Region (2018-2023)
Figure 22. Global Chagas Disease Drug Sales Quantity Market Share by Region (2024-2034)
Figure 23. North America Chagas Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. North America Chagas Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Chagas Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. Europe Chagas Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Chagas Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. China Chagas Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. APAC Chagas Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. APAC Chagas Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 32. Middle East, Africa and Latin America Chagas Disease Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Chagas Disease Drug Sales Quantity in 2024
Figure 34. The Top 10 and Top 5 Players Market Share by Chagas Disease Drug Revenue in 2024
Figure 35. Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 36. Global Chagas Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 37. Global Chagas Disease Drug Revenue Market Share by Type (2018-2034)
Figure 38. Global Chagas Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 39. Global Chagas Disease Drug Revenue Market Share by Application (2018-2034)
Figure 40. North America Chagas Disease Drug Revenue Market Share by Company in 2024
Figure 41. North America Chagas Disease Drug Sales Quantity Market Share by Company in 2024
Figure 42. North America Chagas Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 43. North America Chagas Disease Drug Revenue Market Share by Type (2018-2034)
Figure 44. North America Chagas Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 45. North America Chagas Disease Drug Revenue Market Share by Application (2018-2034)
Figure 46. North America Chagas Disease Drug Revenue Share by Country (2018-2034)
Figure 47. North America Chagas Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 48. U.S. Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 49. Canada Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 50. Europe Chagas Disease Drug Sales Quantity Market Share by Company in 2024
Figure 51. Europe Chagas Disease Drug Revenue Market Share by Company in 2024
Figure 52. Europe Chagas Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 53. Europe Chagas Disease Drug Revenue Market Share by Type (2018-2034)
Figure 54. Europe Chagas Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 55. Europe Chagas Disease Drug Revenue Market Share by Application (2018-2034)
Figure 56. Europe Chagas Disease Drug Revenue Share by Country (2018-2034)
Figure 57. Europe Chagas Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 58. Germany Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 59. France Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 60. U.K. Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 61. Italy Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 62. Russia Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 63. China Chagas Disease Drug Sales Quantity Market Share by Company in 2024
Figure 64. China Chagas Disease Drug Revenue Market Share by Company in 2024
Figure 65. China Chagas Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 66. China Chagas Disease Drug Revenue Market Share by Type (2018-2034)
Figure 67. China Chagas Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 68. China Chagas Disease Drug Revenue Market Share by Application (2018-2034)
Figure 69. APAC Chagas Disease Drug Sales Quantity Market Share by Company in 2024
Figure 70. APAC Chagas Disease Drug Revenue Market Share by Company in 2024
Figure 71. APAC Chagas Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 72. APAC Chagas Disease Drug Revenue Market Share by Type (2018-2034)
Figure 73. APAC Chagas Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 74. APAC Chagas Disease Drug Revenue Market Share by Application (2018-2034)
Figure 75. APAC Chagas Disease Drug Revenue Share by Region (2018-2034)
Figure 76. APAC Chagas Disease Drug Sales Quantity Share by Region (2018-2034)
Figure 77. Japan Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 78. South Korea Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 79. China Taiwan Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 80. Southeast Asia Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 81. India Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Chagas Disease Drug Revenue Market Share by Company in 2024
Figure 84. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Chagas Disease Drug Revenue Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Chagas Disease Drug Revenue Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Chagas Disease Drug Sales Quantity Share by Country (2018-2034)
Figure 89. Middle East, Africa and Latin America Chagas Disease Drug Revenue Share by Country (2018-2034)
Figure 90. Brazil Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Mexico Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 92. Turkey Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Israel Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 94. GCC Countries Chagas Disease Drug Revenue (2018-2034) & (US$ Million)
Figure 95. Chagas Disease Drug Value Chain
Figure 96. Chagas Disease Drug Production Process
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed